Chemical modification of deoxycytidine at different sites yields adducts of different stabilities. Characterization of N3- and O2-deoxycytidine and N3-deoxyuridine adducts of butadiene monoxide

Archives of Biochemistry and Biophysics

Volumn 343, Issue 1, 1997, Pages 63-72

  Selzer, Rebecca R ^a   Elfarra, Adnan A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

1,3 butadiene; Butadiene monoxide; Chemical carcinogenesis; Deoxycytidine adducts; Deoxyuridine adducts; DNA adducts; Hydrolytic deamination

Indexed keywords

1,2 EPOXY 3 BUTENE; 1,3 BUTADIENE DERIVATIVE; DEOXYCYTIDINE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; DEAMINATION; DNA ADDUCT; DNA ALKYLATION; HEATING; KINETICS; MUTAGENESIS; PRIORITY JOURNAL; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0031195140     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.1997.0164     Document Type: Article

References (25)

1. 1. Perera, F. P. (1988) Mutat. Res. 205, 225-269.
2. 2. Shields, P. G., and Harris, C. C. (1991) JAMA 266, 681-687.
3. 3. Dipple, A., Pigott, M. A., Bigger, C. A. H., and Blake, D. M. (1984) Carcinogenesis 5, 1087-1090.
4. 4. Dipple, A., Pigott, M. A., Agarwal, S. K., Yagi, H., Sayer, J. M., and Jerina, D. M. (1987) Nature 327, 535-536.
5. 5. Segerbäck, D., and Kadlubar, F. F. (1992) Carcinogenesis 13, 1587-1592.
6. 6. Silk, N. A., Lay, J. A., Jr., and Martin, C. N. (1989) Biochem. Pharmacol. 38, 279-287.
7. 7. Cochrane, J. E., and Skopek, T. R. (1994) Carcinogenesis 15, 719-723.
8. 8. Van Duuren, B. L., Nelson, N., Orris, L., Palmes, E. D., and Schmitt, F. L. (1963) J. Natl. Cancer Inst. 31, 41-55.
9. 9. Selzer, R. R., and Elfarra, A. A. (1996) Chem. Res. Toxicol. 9, 126-132.
10. 10. Selzer, R. R., and Elfarra, A. A. (1996) Chem. Res. Toxicol. 9, 875-881.
11. 11. Solomon, J. J., Mukai, F., Fedyk, J., and Segal, A. (1988) Chem.-Biol. Interact. 67, 275-294.
12. 12. Solomon, J. J., Singh, U. S., and Segal, A. (1993) Chem.-Biol. Interact. 88, 115-135.
13. 13. Singh, U. S., Decker-Samuelian, K., and Solomon, J. J. (1996) Chem.-Biol. Interact. 99, 109-128.
14. 14. Li, F., Segal, A., and Solomon, J. J. (1992) Chem.-Biol. Interact. 83, 35-54.
15. 15. Segal, A., Solomon, J. J., and Mukai, F. (1990) Cancer Biochem. Biophys. 11, 59-67.
16. 16. Snow, E. T., Singh, J., Koenig, L., and Solomon, J. J. (1994) Environ. Mol. Mutagen. 23, 274-280.
17. 17. Bhanot, O. S., Singh, U. S., and Solomon, J. J. (1994) J. Biol. Chem. 269, 30056-30064.
18. 18. Selzer, R. R., and Elfarra, A. A. (1997) Fundam. Appl. Toxicol. (Suppl.) 36, 309.
19. 19. Sadtler Research Laboratories Inc. (1978) Standard Proton NMR Collection, Spectra 41580M, Philadelphia, PA.
20. 20. Singer, B., and Grunberger, D. (1983) Molecular Biology of Mutagens and Carcinogens, Plenum, New York.
21. 21. Djuric, Z., and Sinsheimer, J. E. (1984) Chem. Biol. Interact. 50, 219-231.
22. 22. Qian, C., and Dipple, A. (1995) Chem. Res. Toxicol. 8, 289-395.
23. 23. Singer, B. (1976) FEBS Lett. 63, 85-88.
24. 24. Singer, B., Kroger, M., and Carrano, M. (1978) Biochemistry 17, 1246-1250.
25. 25. Savela, K., Hesso, A., and Hemminki, K. (1986) Chem.-Biol. Interact. 60, 235-246.